Age-Related Macular Degeneration and Mitochondria-Associated Autoantibodies: A Review of the Specific Pathogenesis and Therapeutic Strategies.
Sichang QuHao LinNorbert PfeifferFranz H GrusPublished in: International journal of molecular sciences (2024)
Age-related macular degeneration (AMD) is a severe retinal disease that causes irreversible visual loss and blindness in elderly populations worldwide. The pathological mechanism of AMD is complex, involving the interactions of multiple environmental and genetic factors. A poor understanding of the disease leads to limited treatment options and few effective prevention methods. The discovery of autoantibodies in AMD patients provides an opportunity to explore the pathogenesis and treatment direction of the disease. This review focuses on the mitochondria-associated autoantibodies and summarizes the functional roles of mitochondria under physiological conditions and their alterations during the pathological states. Additionally, it discusses the crosstalk between mitochondria and other organelles, as well as the mitochondria-related therapeutic strategies in AMD.
Keyphrases
- age related macular degeneration
- cell death
- endoplasmic reticulum
- reactive oxygen species
- systemic lupus erythematosus
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- small molecule
- prognostic factors
- patient reported outcomes
- climate change
- diabetic retinopathy
- dna methylation
- early onset
- gene expression
- drug induced
- copy number
- genetic diversity
- smoking cessation